Susquehanna International Group’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2013
Q4
Sell
-306,100
Closed -$3.86M 9755
2013
Q3
$3.86M Buy
306,100
+281,600
+1,149% +$3.73M ﹤0.01% 3096
2013
Q2
$355K Buy
+24,500
New +$357K ﹤0.01% 6550

Susquehanna International Group's OPTR Position: Q4 2013 in Review

Susquehanna International Group sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 566,565 shares — an estimated $7.14M sold.

Susquehanna International Group first reported a position in OPTR in Q2 2013 and held it in 2 quarters. The position peaked at $7.14M in Q3 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.

  • Susquehanna International Group reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
  • Susquehanna International Group sold 566,565 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $7.14M.
  • Susquehanna International Group first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q2 2013 and held it in 2 quarters.
  • Susquehanna International Group's OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $7.14M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.

Based on Susquehanna International Group's 13F filing for Q4 2013, filed 13 Feb 2014.